Skip Navigation

Amy L. Billett, MD


Pediatric Hematology/Oncology

Make an Appointment

Physician

  • Director of Safety and Quality, Division of Pediatric Hematology/Oncology
  • Institute Physician
  • Associate Professor of Pediatrics, Harvard Medical School

Clinical Interests

  • Electronic health records
  • Global health
  • Lymphoma (Hodgkin and Non-Hodgkin)
  • Management of nausea and vomiting
  • Patient safety
  • Quality improvement

Contact Information

  • Appointments888-733-4662 (new)
    617-632-3270 (established)
  • Office Phone Number617-632-5640
  • Fax617-632-4811

Bio

Dr. Billett received her MD from Harvard Medical School in 1984. After completing a residency in pediatrics at the University of Washington Hospitals, she completed a fellowship in pediatric hematology-oncology at Children's Hospital Boston and Dana-Farber Cancer Institute and became a staff physician in the pediatric hematology/oncology program in 1990. She was the medical director of the inpatient oncology service at Children's Hospital 1995-2005.

Dr. Billett has participated in multiple projects involving improving systems of care, including development of a pediatric chemotherapy order entry system, implementation of the joint CH-DFCI pediatric electronic health record. She is currently the medical director for patient safety and quality in the pediatric hematology/oncology program, the leader of the pediatric lymphoma program, and an active clinician in the program.

She is a clinical faculty leader of the newly established national collaborative to reduce catheter-associated blood stream infections in pediatric hematology/oncology patients.

Board Certification:

  • Pediatric Hematology/Oncology, 2001

Fellowship:

  • Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology

Residency:

  • University of Washington Hospitals

Medical School:

  • Harvard Medical School

Recent Awards:

  • Leadership Development for Physicians, Harvard Medical School, Boston, MA 2003

Research

Hodgkin's Disease in Children, CLABSI-reduction

Our program has been an active member of a small national consortium for clinical trials in pediatric Hodgkins since 1990. pediatric Hodgkin's disease. We currently have three open trials looking at improving/maintaining efficacy while minimizing long-term toxicity.Our center is a founding member of a national quality improvement collaborative started in 2009 to reduce catheter-associated blood stream infections in pediatric hematology-oncology patients. The focus of the collaborative is reliable implementation of best central line maintenance care.

Ozuah NW, Marcus KJ, LaCasce AS, Billett AL. Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma. J Pediatr Hematol Oncol. 2017 Dec 29.
View in: PubMed

Ozuah NW, Dahmoush HM, Grant FD, Lehmann LE, LaCasce AS, Billett AL, Margossian SP. Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation. Pediatr Blood Cancer. 2018 Jan; 65(1).
View in: PubMed

Song H, Todd P, Chiarle R, Billett AL, Gellis S. Primary Cutaneous B-Cell Lymphoblastic Lymphoma Arising from a Long-Standing Lesion in a Child and Review of the Literature. Pediatr Dermatol. 2017 Jul; 34(4):e182-e186.
View in: PubMed

Gaur AH, Bundy DG, Werner EJ, Hord JD, Miller MR, Tang L, Lawlor JP, Billett AL. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients. Infect Control Hosp Epidemiol. 2017 06; 38(6):690-696.
View in: PubMed

Belderson KM, Billett AL. Chemotherapy safety standards: A pediatric perspective. Pediatr Blood Cancer. 2017 Jun; 64(6).
View in: PubMed

Belderson KM, Billett AL. Chemotherapy Safety Standards: A Pediatric Perspective. J Pediatr Oncol Nurs. 2017 May/Jun; 34(3):156-159.
View in: PubMed

Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvet BE, Hendricks C, LeFebvre KB, Mangu PB, McNiff K, Olsen M, Schulmeister L, Von Gehr A, Polovich M. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology Oncol Nurs Forum. 2017 01 06; 44(1):31-43.
View in: PubMed

Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvey BE, Hendricks C, LeFebvre KB, Mangu PB, McNiff K, Olsen M, Schulmeister L, Von Gehr A, Polovich M. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. J Oncol Pract. 2016 Dec; 12(12):1262-1271.
View in: PubMed

Wong Quiles CI, Gottsch S, Thakrar U, Fraile B, Billett AL. Health care institutional charges associated with ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients. Pediatr Blood Cancer. 2017 Feb; 64(2):324-329.
View in: PubMed

Hord JD, Lawlor J, Werner E, Billett AL, Bundy DG, Winkle C, Gaur AH. Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines. Pediatr Blood Cancer. 2016 09; 63(9):1603-7.
View in: PubMed

Bundy DG, Gaur AH, Hord JD, Miller MR, Werner EJ, Winkle C, Billett A. Burden of bloodstream infections among ambulatory pediatric hematology/oncology patients with a central line. J Clin Oncol. 2016 Mar; 34(7_suppl):262.
View in: PubMed

Santacroce E, Zimmerman MA, Freeman M, Lau Greenberg T, Nguyen P, Chi SN, Bandopadhayay P, Lane S, Szabatura A, Houlahan K, Billett A. Building a new process: Nursing verification of pediatric oral chemotherapy. J Clin Oncol. 2016 Mar; 34(7_suppl):199.
View in: PubMed

Green AL, Yi J, Bezler N, Pikman Y, Tubman VN, Obeng EA, O'Neil T, Mersereau R, Morrissey L, Billett AL. A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients. Pediatr Blood Cancer. 2016 Jan; 63(1):112-7.
View in: PubMed

Bundy DG, Gaur AH, Billett AL, He B, Colantuoni EA, Miller MR. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results. Pediatrics. 2014 Dec; 134(6):e1678-85.
View in: PubMed

Billett AL. Avoiding risky business: supporting optimal home medication administration for children with cancer. J Oncol Pract. 2014 Nov; 10(6):377-9.
View in: PubMed

Archer N, Collins NB, Croteau S, Hong AL, Kamihara J, Kim D, Kort K, Mersereau R, Mosadegh S, Billett A. Use of a fever fast track tool to reduce time to antibiotic dose in febrile pediatric oncology patients. J Clin Oncol. 2014 Oct 20; 32(30_suppl):222.
View in: PubMed

Zenlea IS, Billett A, Hazen M, Herrick DB, Nakamura MM, Jenkins KJ, Woolf AD, Kesselheim JC. Trainee and program director perceptions of quality improvement and patient safety education: preparing for the next accreditation system. Clin Pediatr (Phila). 2014 Nov; 53(13):1248-54.
View in: PubMed

Kelly ME, Lu X, Devidas M, Camitta B, Abshire T, Bernstein ML, Billett A, Homans A, Sandler E, Buchanan G. Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9). J Pediatr Hematol Oncol. 2013 Oct; 35(7):509-13.
View in: PubMed

Croteau SE, Henderson ER, Billett AL, Gebhardt MC, Voss SD. Resolving bony abnormality evolves to diffuse large B-cell lymphoma. Pediatr Blood Cancer. 2013 Oct; 60(10):E113-5.
View in: PubMed

Billett AL, Colletti RB, Mandel KE, Miller M, Muething SE, Sharek PJ, Lannon CM. Exemplar pediatric collaborative improvement networks: achieving results. Pediatrics. 2013 Jun; 131 Suppl 4:S196-203.
View in: PubMed

Friedmann AM, Wolfson JA, Hudson MM, Weinstein HJ, Link MP, Billett A, Larsen EC, Yock T, Donaldson SS, Marcus K, Krasin MJ, Howard SC, Metzger ML. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer. 2013 Sep; 60(9):1458-63.
View in: PubMed

Walsh KE, Roblin DW, Weingart SN, Houlahan KE, Degar B, Billett A, Keuker C, Biggins C, Li J, Wasilewski K, Mazor KM. Medication errors in the home: a multisite study of children with cancer. Pediatrics. 2013 May; 131(5):e1405-14.
View in: PubMed

Kelly MS, Conway M, Wirth KE, Potter-Bynoe G, Billett AL, Sandora TJ. Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: a single institution experience of 41 cases. J Pediatr Hematol Oncol. 2013 Mar; 35(2):e71-6.
View in: PubMed

Gaur AH, Bundy DG, Gao C, Werner EJ, Billett AL, Hord JD, Siegel JD, Dickens D, Winkle C, Miller MR. Surveillance of hospital-acquired central line-associated bloodstream infections in pediatric hematology-oncology patients: lessons learned, challenges ahead. Infect Control Hosp Epidemiol. 2013 Mar; 34(3):316-20.
View in: PubMed

Metzger ML, Billett A, Link MP. The impact of drug shortages on children with cancer--the example of mechlorethamine. N Engl J Med. 2012 Dec 27; 367(26):2461-3.
View in: PubMed

Metzger ML, Weinstein HJ, Hudson MM, Billett AL, Larsen EC, Friedmann A, Howard SC, Donaldson SS, Krasin MJ, Kun LE, Marcus KJ, Yock TI, Tarbell N, Billups CA, Wu J, Link MP. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA. 2012 Jun 27; 307(24):2609-16.
View in: PubMed

Billett AL, Reaman GH. What price cure? Pediatr Blood Cancer. 2011 Dec 01; 57(6):908-9.
View in: PubMed

Kelly M, Conway M, Wirth K, Potter-Bynoe G, Billett AL, Sandora TJ. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients. Infect Control Hosp Epidemiol. 2011 Nov; 32(11):1079-85.
View in: PubMed

Ashworth LA, Billett A, Mitchell P, Nuti F, Siegel C, Bousvaros A. Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort. Inflamm Bowel Dis. 2012 May; 18(5):838-43.
View in: PubMed

Metzger M, Weinstein HJ, Hudson MM, Billett A, Larsen EC, Friedmann AM, Donaldson SS, Krasin MJ, Kun LE, Marcus KC, Yock TI, Tarbell N, Billups C, Wu J, Link MP. Results of a prospective clinical trial for VAMP alone without irradiation for pediatric favorable, early-stage Hodgkin lymphoma patients who achieve an early complete response. J Clin Oncol. 2011 May 20; 29(15_suppl):9503.
View in: PubMed

Lowry RJ, Billett A, Buchanan C, Whiston S. Increasing breastfeeding and reducing smoking in pregnancy: a social marketing success improving life chances for children. Perspect Public Health. 2009 Nov; 129(6):277-80.
View in: PubMed

Feusner JH, Ritchey AK, Cohn SL, Billett AL. Management of tumor lysis syndrome: need for evidence-based guidelines. J Clin Oncol. 2008 Dec 01; 26(34):5657-8; author reply 5658-9.
View in: PubMed

Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007 Jan 20; 25(3):332-7.
View in: PubMed

Donaldson SS, Link MP, Weinstein HJ, Rai, SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KJ, Tarbell NJ, Young JA, Hudson MM. Final Results of a Prospective Clinical Trial with VAMP and Low-Dose Involved-Field Radiation for Children with Low-Risk Hodgkin’s Disease. JCO. 2007; 25(3):332-7.
View in: PubMed

Barredo JC, Devidas M, Lauer SJ, Billett A, Marymont M, Pullen J, Camitta B, Winick N, Carroll W, Ritchey AK. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. J Clin Oncol. 2006 Jul 01; 24(19):3142-9.
View in: PubMed

Sandler ES, Homans A, Mandell L, Amylon M, Wall DA, Devidas M, Buchanan GR, Lipton JM, Billett AL. Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group pilot feasibility study. J Pediatr Hematol Oncol. 2006 Apr; 28(4):210-5.
View in: PubMed

Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood. 2006 Jun 15; 107(12):4961-7.
View in: PubMed

Mueller B, Billett AL. Regulating Patient Safety in Cancer Treatment. Pizzo PA & Poplak DF, eds. Principles and Practice of Pediatric Oncology. 2006; 525-537.
View in: PubMed

Berde C, Collins JJ, Billett AL. Symptom management in supportive care. Pizzo PA & Poplack DC, eds. Principles and Practice of Pediatric Oncology. 2006; 1348-1379.
View in: PubMed

Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. J Clin Oncol. 2005 May 20; 23(15):3376-82.
View in: PubMed

Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys. 2005 Feb 01; 61(2):374-9.
View in: PubMed

Dinning C, Branowicki P, O'Neill JB, Marino BL, Billett A. Chemotherapy error reduction: a multidisciplinary approach to create templated order sets. J Pediatr Oncol Nurs. 2005 Jan-Feb; 22(1):20-30.
View in: PubMed

Donaldson SS, Tarbell NJ, Weinstein HJ, Link MP, L Kun, Billett AL, Marcus KC, Hurwitz CA, Young JA, Brain S, Hudson MM. End Results of a Prospective Clinical Trial with VAMP and Low-dose, Involved-Field Radiation for Pediatric Patients with Favorable, Early-Stage Hodgkin’s Disease. American Society for Therapeutic Radiation and Oncology. 2005.
View in: PubMed

Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billett AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KJ, Rai S, Cowan T, Weinstein HJ. Risk-adapted combined modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol. 2004; 22(22):4541-4550.
View in: PubMed

Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, Billett AL, Tarbell NJ. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery. 2003 Jun; 52(6):1348-56; discussion 1356-7.
View in: PubMed

Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol. 2003 May 15; 21(10):2026-33.
View in: PubMed

Branowicki P, O'Neill JB, Dwyer JL, Marino BL, Houlahan K, Billett A. Improving complex medication systems: an interdisciplinary approach. J Nurs Adm. 2003 Apr; 33(4):199-200.
View in: PubMed

Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys. 2003 Apr 01; 55(5):1182-5.
View in: PubMed

Donaldson SS, Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, Marcus KC, Hurwitz CA, Young JA, Tarbell NJ, Weinstein HJ. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol. 2002 Jul 15; 20(14):3081-7.
View in: PubMed

LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, Barr R, Clavell LA, Asselin B, Hurwitz C, Schorin M, Lipshultz SE, Declerck L, Silverman LB, Cohen HJ, Sallan SE. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01. J Clin Oncol. 2002 Jan 01; 20(1):237-46.
View in: PubMed

Marino BL, Branowicki P, Bennett JA, Houlahan K, O'Neill JB, Dwyer JL, Billett A. Evaluating process changes in a pediatric hospital medication system. Outcomes Manag. 2002 Jan-Mar; 6(1):10-5; quiz 16.
View in: PubMed

Berde C, Collins JJ, Billett AL. Symptom management in supportive care. Pizzo PA & Poplack DC, eds. Principles and Practice of Pediatric Oncology. 2002; 1301-1332.
View in: PubMed

Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL. Memory deficits among children with craniopharyngiomas. Neurosurgery. 2001 Nov; 49(5):1053-7; discussion 1057-8.
View in: PubMed

Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL. Memory deficits in children with craniopharyngioma. Neurosurgery. 2001; 49(5):1-6.
View in: PubMed

Kieran MW, Billett A. Antiangiogenesis therapy. Current and future agents. Hematol Oncol Clin North Am. 2001 Oct; 15(5):835-51, viii.
View in: PubMed

Tzika AA, Zurakowski D, Poussaint TY, Goumnerova L, Astrakas LG, Barnes PD, Anthony DC, Billett AL, Tarbell NJ, Scott RM, Black PM. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology. 2001 Feb; 43(2):169-77.
View in: PubMed

Abshire TC, Pollock BH, Billett AL, Bradley P, Buchanan GR. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood. 2000 Sep 01; 96(5):1709-15.
View in: PubMed

Silverman LB, Billett AL. High dose therapy in acute lymphoblastic leukemia. Armitage JA and Antman KH, eds. High Dose Cancer Therapy: Pharmacology, Hematopoietins and Stem Cells. 2000; 691-703.
View in: PubMed

Zhou M, Gu L, Abshire TC, Homans A, Billett AL, Yeager AM, Findley HW. Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia. Leukemia. 2000 Jan; 14(1):61-7.
View in: PubMed

Billett AL, Dinning C, Marino B, Lucich J, and Branowicki P. Chemotherapy order templates created by a multidisciplinary team reduced changes in signed chemotherapy orders. Journal of Pediatric Hematology/Oncology. 2000; 22(649):384.
View in: PubMed

Kim JYH, Sutton ME, Lu DJ, Cho TA, Goumnerova LC, Goritchenko L, Kaufman JR, Lam KK, Billett AL, et al. Activation of neutrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Research. 1999; 59(3):711-719.
View in: PubMed

Billett AL, Ritz J. Autologous hematopoietic cell transplantation for acute lymphoblastic leukemia. Thomas ED, Blume KG, and Forman SJ, eds. Hematopoietic Cell Transplantation. 1999; 978-989.
View in: PubMed

Silverman LB, Billett AL, Sallan SE. Treatment of acute leukemia in children. Gellis & Kagan’s Current Pediatric Therapy. 1999; 717-721.
View in: PubMed

Abdalla HI, Billett A, Kan AK, Baig S, Wren M, Korea L, Studd JW. Obstetric outcome in 232 ovum donation pregnancies. Br J Obstet Gynaecol. 1998 Mar; 105(3):332-7.
View in: PubMed

Homans A, Kurtzberg J, Pollock B, DeOliveira D, Billett A. Comparison of polyethylene glycol conjugated (PEG) L-Asparaginase (ASP) with native E.coli ASP for induction therapy of relapsed childhood acute lymphoblastic leukemia (ALL): A Pediatric Oncology Group study. Proc Am Soc Clin Oncol. 1998; 17(851):221a.
View in: PubMed

Billett AL, Gelber RD, Tarbell NJ, Dalton V, Donnelly M, Sallan SE. Results of Dana-Farber Cancer Institute consortium childhood acute lymphoblastic leukemia protocols. Int J Ped Hem Onc. 1998; 5(2-4):115-123.
View in: PubMed

Lehmann LE, Tarbell NJ, Renella R, Sallan SE, Weinstein HJ, Billett AL. Excellent outcome for pediatric patients with mediastinal lymphoblastic lymphoma when treated with intensive acute lymphoblastic leukemia therapy. Am Soc Hem. 1998; 92(10 (Suppl 1 No. 1)):620a.
View in: PubMed

Dutton SC, Billett AL, Kieran MW, Barnes P, Black PM, Goumnerova LC, Scott RM, LaVally B, Leong T, Pomeroy S, Tarbell NJ. Fractionated stereotactic radiation therapy for craniopharyngioma: Preliminary results of a prospective study. 8th International Symposium on Pediatric Neuro-Oncology. Rome. 1998.
View in: PubMed

Duerst RE, Liesveld J, Rapaport A, Abboud C, Billett AL. Autologous stem cell rescue for high-risk central nervous system tumors: phase I study of cyclophosphamide, carboplatin and melphalan. American Society of Blood and Marrow Transplantation, Miami Beach, FL. 1998.
View in: PubMed

Weisdorf DJ, Billett AL, Hannan P, Ritz J, Sallan SE, Steinbuch M, Ramsay NK. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood. 1997 Oct 15; 90(8):2962-8.
View in: PubMed

Tao ML, Barnes PD, Billett AL, Leong T, Shrieve DC, Scott RM, Tarbell NJ. Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys. 1997 Oct 01; 39(3):579-87.
View in: PubMed

Hardenbergh PH, Golden J, Billett AL, Scott RM, Shrieve DC, Silver B, Loeffler JS, Tarbell NJ. Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys. 1997; 39(2):419-426.
View in: PubMed

McLendon RE, Bentley RC, Parisi JE, Tien RD, Harrison JC, Tarbell NJ, Billett AL, Gualtieri RJ, Friedman HS. Malignant supratenorial glial-neuronal neoplasms: report of two cases and review of the literature. Arch Pathol Lab Med. 1997; 121(5):485-492.
View in: PubMed

Billett AL, Pollock BH, Abshire TC, Buchanan GR. Outcome of children with B-lineage acute lymphoblastic leukemia (ALL) in first bone marrow relapse. Blood. 1997; 90 (Suppl 1):332a.
View in: PubMed

Billett AL and Sallan SE. Management of nausea and vomiting. Pizzo PA & Poplack DC, eds. Principles and Practice of Pediatric Oncology. 1997; 1201-1208.
View in: PubMed

Farah RA, Billett AL, Pollock BH, Buchanan GR, Schneider NR. Significance of cytogenetic findings in childhood acute lymphoblastic leukemia (ALL) at first marrow relapse. A Pediatric Oncology Group study. Blood. 1997; 90 (Suppl 1):185a.
View in: PubMed

Bakardjiev AI, Barnes PD, Goumnerova LC, Black PM, Scott RM, Pomeroy SL, Billett A, Loeffler JS, Tarbell NJ. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer. 1996 Aug 15; 78(4):864-73.
View in: PubMed

Cardoso AA, Schultze JL, Boussiotis VA, Freeman GL, Seamon MJ, Laszlo S, Billett AL, Sallan SE, Gribben JG, Nadler LM. Pre-B acute lymphoblastic leukemia cell may introduce T-cell anergy to alloantigen. Blood. 1996; 88(8):41-48.
View in: PubMed

Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Bone Marrow Transplant. 1996 May; 17(5):763-8.
View in: PubMed

Tarbell NJ, Scott RM, Goumnerova LC, Pomeroy SL, Black PM, Barnes P, Billett AL, LaVally B, Shrieve D, Helmus A, Kooy HM, Loeffler JS. Craniopharyngioma: Preliminary results of stereotactic radiation therapy. Radiosurgery. 1996; 1995:75-82.
View in: PubMed

Billett AL, Soiffer RJ, Eickhoff C, Donnelly M, Tarbell NJ, Weinstein HJ, Sallan SE, Ritz J. Monoclonal antibody-purged autologous bone marrow transplantation for acute lymphoblastic leukemia in children and adults at high risk of relapse: The Dana-Farber Cancer Institute experience. In Dicky KA, ed. Autologous Bone Marrow Transplantation: Proceedings of the Seventh International Symposium. 1995; 7:145-156.
View in: PubMed

Laufer MR, Billett AL, Diller LR, Chin LM, Tarbell NJ. A new technique for laparoscopic prophylactic oophoropexy before cranial irradiation in children with medulloblastoma. Adolescent and Pediatric Gynecology. 1995; 8:77-81.
View in: PubMed

Billett AL, Sallan SE. Antiemetics in children receiving cancer chemotherapy. Support Care Cancer. 1994 Sep; 2(5):279-85.
View in: PubMed

Billett AL and Sallan SE. Acute lymphoblastic leukemia. Cassidy JR, ed. Pediatric Radiation Oncology. 1994; 87-97.
View in: PubMed

Billett AL, Abshire TC, Pollock BH, Buchanan GR. Second remission and early outcome for children with B-lineage acute lymphoblastic leukemia in first bone marrow relapse. Blood. 1994; 84 (Suppl 1):148a.
View in: PubMed

Dutton S, Billett AL, Sallan S, Barnes P, Goumnerova L, Pomeroy S, Leong T, Loeffler J, Tarbell N. Medulloblastoma: Prognostic significance of postoperative tumor and response to chemotherapy. Proc Am Soc Clin Oncol. 1994; 13(514):181.
View in: PubMed

Skapek S, Goumnerova L, Leong T, LaVally B, Helmus A, Billett AL, Sallan S, Tarbell N. . Clinical outcome in children with central nervous system primitive neuroectodermal tumor (CNS PNET) outside of the posterior fossa (PF). Proc Am Soc Clin Oncol. 1994; 13(497):177.
View in: PubMed

Tarbell NJ, Barnes P, Scott RM, Goumnerova L, Pomeroy S, Black PM, Sallan SE, Billett AL, LaVally B, Helmus A, Kooy HM, Loeffler. Advances in radiation therapy for craniopharyngioma. Ped Neurosurg. 1994; 21 (suppl 1):101-107.
View in: PubMed

Tarbell NJ, Barnes P, Scott RM, Goumnerova L, Pomeroy SL, Black PM, Sallan SE, Billett A, LaVally B, Helmus A, et al. Advances in radiation therapy for craniopharyngiomas. Pediatr Neurosurg. 1994; 21 Suppl 1:101-7.
View in: PubMed

Billett AL, Sallan SE. Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging. Am J Pediatr Hematol Oncol. 1993 May; 15(2):162-8.
View in: PubMed

Billett AL, Kornmehl E, Tarbell NJ, Weinstein HJ, Gelber RD, Ritz J, Sallan SE. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood. 1993 Mar 15; 81(6):1651-7.
View in: PubMed

Billett AL and Sallan SE. Treatment of acute leukemia in children. In Burg FD, Ingelfinger JR, and Wald ER, eds. Current Pediatric Therapy. 1993; 267-270.
View in: PubMed

Billett AL and Sallan SE. Autologous bone transplantation in childhood acute lymphoblastic leukemia with use of purging. AM J Ped Hem Onc. 1993.
View in: PubMed

Billett AL and Sallan SE. Management of nausea and vomiting. In Pizzo PA and Poplack DG, eds. Principles and Practices of Pediatric Oncology. 1993; 1051-1057.
View in: PubMed

Billett AL, Carls A, Gelber RD, Sallan SE. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer. 1992 Jul 01; 70(1):201-6.
View in: PubMed

Billett AL, Tarbell N, Donnelly M, Gelber R, Weinstein H, Ritz J, Sallan S. Autologous bone marrow transplantation for relapsed childhood acute lymphoblastic leukemia after a short first remission. Blood. 1992; 80 (Suppl 1):24a.
View in: PubMed

Billett AL. High dose therapy in acute lymphoblastic leukemia. Armitage JA and Antman KH, eds. High dose cancer therapy. Pharmacology, hematopoietins and stem cells. 1992; 607-618.
View in: PubMed

Billett AL and Sallan SE. Acute leukemia in childhood. In: Brian MC, and Carbone PP, eds. Current therapy in hematology-oncology-4. 1992; 67-73.
View in: PubMed

Soiffer RJ, Billett AL, Roy DC, Dalton V, Sallan SE, Ritz J. Autologous bone marrow transplantation for acute lymphoblastic leukemia in second or subsequent complete remission: Ten years experience at the Dana-Farber Cancer Institute. In Dicky KA, Armitage JO & Dicky MJ eds. Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium. Ebinger. 1991; 167-176.
View in: PubMed

Garber JE, Burke EM, Lavally BL, Billett AL, Sallan SE, Scott RM, Kupsky W, Li FP. Choroid plexus tumors in the breast cancer-sarcoma syndrome. Cancer. 1990 Dec 15; 66(12):2658-60.
View in: PubMed

Sallan SE, Niemeyer CM, Billett AL, Lipton JM, Tarbell NJ, Gelber RD, Murray C, Pittinger TP, Wolfe LC, Bast RC, et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia. J Clin Oncol. 1989 Nov; 7(11):1594-601.
View in: PubMed

Billett AL, Baas F, Raponi R, Croop JM, Arceci RJ. mdr1 and mdr3 expression in patients with leukemia. Blood. 1988; 74:346a.
View in: PubMed

Jones GP, Hooper PT, Rivett DE, Tucker DJ, Lambert G, Billett A. Nephrotoxic activity in rats fed diets containing DL-3-(N-phenylethylamino)-alanine. Aust J Biol Sci. 1987; 40(2):115-23.
View in: PubMed

Polaner DM, Billett AL, Richardson MA. Cardiovocal syndrome. Pediatrics. 1986; 78(2):380.
View in: PubMed

Research Departments:

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Shields Warren 360
Boston MA, 02215
Get Directions

Top